Bleeding edge

The latest signals, before they hit the news.

New preprints, nonprofit research updates, and science releases on the type 1 diabetes cure, surfaced early and labeled honestly. Preprints are the earliest data: small studies, not yet peer reviewed, and exactly where breakthroughs first show up.

11 signals · updated Sep 9, 2026

Preprints are not peer reviewed and early findings often change. This lane is for the earliest research signal, clearly labeled. It is information, not medical advice.

Breakthrough T1Dnonprofit updateCure signalAug 11, 2026

An Interview with Breakthrough T1D-Funded Researchers

A cornerstone of Breakthrough T1D is awarding funding to scientists, researchers, and clinicians who are embarking on promising type 1 diabetes (T1D) research projects. The research we fund spans across the entire spectrum of T1D, including underlying biological and genetic causes, new approaches to cures, advanced te…

Read the source
Breakthrough T1Dnonprofit updateAug 11, 2026

Ride Pat Ride: Cycling from the Pacific to the Atlantic for T1D

Embarking on a cross-country cycling odyssey requires a lot of planning. For Pat McAleer, the journey began in 2009, when his daughter Mary Kate was diagnosed with type 1 diabetes (T1D) at 10 years old, as she navigated the daily challenges of this condition with incredible strength. “Since then, my wife Molly and I h…

Read the source
Breakthrough T1Dnonprofit updateAug 11, 2026

Global Summit to End Diabetes Stigma

The inaugural Global Summit to End Diabetes Stigma aimed to confront and reduce the stigma that impacts the lives of people with diabetes. The post Global Summit to End Diabetes Stigma appeared first on Breakthrough T1D .

Read the source
Breakthrough T1Dnonprofit updateJul 27, 2026

Tips for Smooth Insulin Injections

We’ve all had moments where insulin injections just don't go the way you want. Get tips for a smooth injection every time. The post Tips for Smooth Insulin Injections appeared first on Breakthrough T1D .

Read the source
bioRxivpreprint (not peer reviewed)Jul 26, 2026

Cryoaerosolization Enables Scalable Vitrification-Based Cell Cryopreservation

Cell therapies hold transformative potential for treating cancer, neurologic disorders, organ failure, diabetes, and other conditions, but their widespread clinical deployment is constrained by the lack of scalable cryopreservation methods that maintain high post-thaw viability. Current standard practice using slow fr…

Read the source
Breakthrough T1Dnonprofit updateJul 24, 2026

Breakthrough T1D Run: “A Full-Circle Moment”

Chris Ronzio was diagnosed with type 1 diabetes (T1D) in 1994, when he was 9 years old. “I’ve now been living with T1D for over 32 years, and it’s woven into every part of my life, as a CEO running a 140-person company, as a competitive endurance athlete who has run marathons on five continents, […] …

Read the source
Breakthrough T1Dnonprofit updateCure signalJul 13, 2026

New Publication: Sana’s Gene-Edited Islets Continue to Make Insulin

What’s Happening? A new publication in The New England Journal of Medicine provides more detail about the first person with type 1 diabetes (T1D) treated with Sana Biotechnology’s gene-edited islets. This person is still making insulin 14+ months after their islet transplant—without immunosuppressants! What to K…

Read the source
Breakthrough T1Dnonprofit updateJul 8, 2026

Two Truths and a Lie: Can You Separate the T1D Facts from Fiction?

Living with type 1 diabetes (T1D) means managing the disease every day while navigating its complexities. That’s why dispelling common myths and misconceptions is so important. They can make life even harder for people living with T1D.  We’re always working to create greater awarenes…

Read the source
Breakthrough T1Dnonprofit updateJul 6, 2026

From T1D Toddler to Resilient Adult: Jessie Stover Shares her Story

Spotlight on Jessie Stover Jessie Stover is the Development Manager at Breakthrough T1D’s Indiana Chapter. Stover was born and raised in Evansville, Indiana, and she now lives in Indianapolis with her two cats, Milo and Zuko. She enjoys reading, crafting, concerts, and “baking gluten-free desserts so good that no one …

Read the source
Breakthrough T1Dnonprofit updateCure signalJul 6, 2026

A Roadmap to Accelerate Cell Therapies into Clinical Trials

What’s Happening? A new Breakthrough T1D publication lays out the first clear preclinical testing and manufacturing roadmap for getting islet cell therapies for type 1 diabetes (T1D) into human clinical trials faster. What is This Publication About? Before any new therapy—including islet cell therapies for T1D—c…

Read the source